Phoenix, AZ Frequently asked questions In the STEP 1 trial published in The New England Journal of Medicine (Wilding et al., 2021), participants on weekly 2.4 mg semaglutide lost an average of 14.9% of body weight at 68 weeks versus 2.4% on placebo
You have tried other weight loss strategies, such as dieting and exercising, but have not achieved your desired results
However, while using semaglutide, it was found that some patients were also losing weight, leading to it being licensed for weight loss in the UK for non-diabetics (Wegovy)
[1] [2] While high-dose oral B12 supplements can be effective through passive diffusion, they are not routinely recommended for pernicious anaemia management in UK practice
They actually treat me like a patient and not just a customer